Monday, 17 August 2015

Wockhardt gets UK approval for neuropathic pain capsule pregabalin

The stock has hit a high of Rs. 1710 and a low of Rs. 1672.


Wockhardt
Wockhardt Ltd has announced that it has received UK approval for neuropathic pain capsule pregabali, according to reports.

The stock was down 1% to Rs. 1691.

The stock has hit a high of Rs. 1710 and a low of Rs. 1672.

No comments:

Post a Comment